Open AccessAbstract 470: High-dose TSLP decreases in vivo tumor burden in preclinical models of CRLF2 B-ALL
Author(s) -
Caleb RuizJiménez,
Jacqueline S. Coats,
Cornelia Stoian,
Ineavely Báez,
Hossam Alkashgari,
Andy Paz-Aldana,
Hannah Choi,
Roland Williams,
Shadi Farzin Gohar,
Sinisa Dovat,
Kimberly J. Payne
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-470
Subject(s) - thymic stromal lymphopoietin , in vivo , cytokine , cancer research , protein kinase b , stat5 , pi3k/akt/mtor pathway , phosphorylation , receptor , medicine , signal transduction , biology , microbiology and biotechnology